Navigation Links
ResMed Takes Action to Enforce Patents Against BMC and 3B

SAN DIEGO, June 5, 2013 /PRNewswire/ -- ResMed (NYSE: RMD), an innovator and pioneer in developing products for the treatment of sleep-disordered breathing and respiratory conditions, has filed a lawsuit in U.S. Federal Court, Southern District of California in San Diego, to stop infringement of ResMed patents.


ResMed filed the action against Chinese medical device manufacturer BMC Medical Co., Ltd. and its U.S. sales subsidiary, 3B Products, LLC, asserting patent infringement by:

  • The RESmart CPAP and RESmart Auto CPAP devices
  • The Willows nasal pillows patient interface and the iVolve nasal mask.
  • ResMed further filed a request to add BMC to its pending International Trade Commission (ITC) case against Taiwanese manufacturer APEX to stop the importation and sales of these products in the United States.

    The ITC case against APEX, filed March 27, 2013, also named Medical Depot, Inc., doing business as Drive Medical Design and Manufacturing, in the patent infringement case. On May 30, Drive Medical Design and Manufacturing filed papers stating that it is prepared to enter into a consent decree promising to stop importation and sales of the APEX products named in the ITC proceeding. 

    "ResMed has built its unique market differentiation by investing in superior technology and medical science-driven innovation for sleep-disordered breathing therapy," said ResMed global general counsel and chief administrative officer David Pendarvis . "We will continue to defend our proprietary technology by enforcing our patents."

    About ResMed:
    ResMed is a global leader in the development, manufacturing and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit

    Contacts:For News MediaFor the Finance and Investor CommunityGretchen GriswoldConstance BienfaitDirector, Global Corporate CommunicationsDirector, Investor RelationsO: 858-836-6789O:

    SOURCE ResMed Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ResMed Launches SleepSeeker Online Tool to Increase Patient Engagement in Therapy for Sleep-Disordered Breathing
    2. The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering
    3. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
    4. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
    5. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
    6. ResMed Takes Action to Enforce Patents
    7. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    8. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
    9. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
    10. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
    11. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
    Post Your Comments:
    (Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
    (Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
    (Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
    (Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
    (Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
    (Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, ... Elite. The attorneys chosen by their peers for this recognition are considered among the ... Traurig Shareholders received special honors as members of this year’s Legal Elite Hall of ...
    Breaking Medicine News(10 mins):